MDM2 and metabolic dysfunction-associated steatohepatitis: Immunohistochemical analysis revealed that hepatic MDM2 was significantly upregulated in obese humans with NASH compared with those without MAFLD (Figure 1E,F; and Table S1, Supporting Information).